What's Going on With Repligen Stock Wednesday? - Repligen (NASDAQ:RGEN), BioLife Solutions (NASDAQ:BLFS)

Repligen to acquire BioLife Solutions for $1.5B to boost cell therapy bioprocessing capabilities and expand global reach.

Raccontata dabenzinga.com